Eli Lilly Launches New Obesity Drug Zepbound in U.S. Pharmacies
INDIANAPOLIS, IN – Pharmaceutical giant Eli Lilly announced the availability of its new obesity treatment, Zepbound, in U.S. pharmacies. The drug, priced at $550 monthly for uninsured patients, is half its list…
